Cookson Peirce & CO Inc Galapagos Nv Transaction History

Cookson Peirce & CO Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2018 Jul 26, 2018	SELL	$88.4 - $105.34 $367,744 - $438,214	-4,160 Closed	0 $0
Q1 2018 May 01, 2018	BUY	$94.51 - $120.23 $9,451 - $12,023	100 Added 2.46%	4,160 $0
Q4 2017 Feb 12, 2018	BUY	$84.48 - $104.02 $47,731 - $58,771	565 Added 16.17%	4,060 $0
Q3 2017 Nov 13, 2017	BUY	$73.17 - $103.47 $32,926 - $46,561	450 Added 14.78%	3,495 $0
Q2 2017 Aug 17, 2017	BUY	N/A	3,045	3,045 $0

17.4M

10.4K

33.1K

Ticker GLPG
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,835,500
Market Cap $1.93B
Description
Galapagos NV, an integrated biopharmaceutical company, engages in the discovery, development, and commercialization of various medicines for high unmet medical need. Its pipeline products include filgotinib, a JAK1 inhibitor that is in various phases of clinical trials for the treatment of rheumatoid arthritis, Crohn's disease, ulcerative coliti...

Get notified when there are updates to the investment portfolio of Cookson Peirce & CO Inc, based on Form 13F filings with the SEC.

Stay updated on Cookson Peirce & CO Inc with notifications on news.